German science and technology group Merck KGaA (MRK: DE) has upgraded its full-year outlook after a second quarter in which its laboratory and semiconductor materials businesses more than covered a ...

UK-based clinical-stage pharma company Actimed Therapeutics today revealed that it has regained exclusive global rights to the anabolic-catabolic transforming agent (ACTA) S-oxprenolol from US biotech ...

US pharma major Eli Lilly (NYSE: LLY) reported second-quarter 2026 revenue of $23 billion, up 48% year-on-year from $15.6 billion in the second quarter of 2025 and well ahead of Wall Street forecasts ...

Adneuris Therapeutics, a wholly-owned subsidiary of Tris Pharma advancing a new kind of pain medicine, announced that it has ...